Webinar
April 29, 2026 | 4pm CET I 10am ET
Moving from Sanger to NGS with Devyser CFTR
Are you still relying on Sanger sequencing for CFTR testing? Discover how laboratories are successfully transitioning to next-generation sequencing (NGS) to streamline workflows and improve diagnostic efficiency. In this webinar, Dr. Aleksandra Divac Rankov from the Institute of Molecular Genetics and Genetic Engineering at the University of Belgrade will share insights on transitioning from traditional Sanger sequencing to the Devyser CFTR NGS solution. Learn how this single-tube NGS-based workflow can simplify complex testing strategies while delivering comprehensive CFTR analysis.
Don’t miss the opportunity to ask your questions directly during the live Q&A session.
Why attend?
- Learn how labs transition from multi-step Sanger workflows to a single NGS-based CFTR testing solution.
- Discover how Devyser CFTR enables detection of variants, including large deletions and duplications, in one workflow.
- Gain insights from a laboratory implementation of NGS-based CFTR testing and its practical benefits.
Can’t attend live?
Everyone who registers will receive access to the on-demand recording after the webinar.
Latest from the Devyser blog
View all
Devyser launches a new updated NGS assay to simplify thalassemia testing
Devyser has launched Devyser Thalassemia v2, a next-generation sequencing (NGS) solution designed...
Read More
Devyser Thalassemia achieves 99.9% sensitivity: Insights from a recent study
Thalassemia and hemoglobinopathies are among the most common genetic disorders worldwide, affecting...
Read More
New insights into thalassemia: Latest studies using Devyser Thalassemia for NGS testing
Read More